aDepartment of Advanced Biomedical Sciences, Federico II University of Naples
bMediterranea Cardiocentro, Napoli
cDepartment of Pharmaceutical Sciences, Università degli Studi di Milano, Milano
dDepartment of Pharmacy, CIRFF, Centre of Pharmacoeconomics, University of Naples Federico II, Napoli
eU.O. Assistenza Farmaceutica Ospedaliera, Territoriale e Ricerca clinica, Ferrara
fDepartment of Oncology and Hemato-oncology, Postgraduate School of Clinical Pharmacology and Toxicology, University of Milan
gClinical Pharmacology Unit, ASST Grande Ospedale Metropolitano Niguarda, Milano
hDepartment of Biomedical and Dental Sciences and Morphofunctional Imaging, University of Messina, Messina
iSocietà Italiana di Medicina Generale (SIMG), Napoli
jU.O.C. Farmaceutica Territoriale, Pisa
kA.O.U.Policlinico Umberto Primo
lArea del Farmaco ASL RM A, Roma
mA.O.U.C. Policlinico di Bari, Bari
nHelaglobe SRL, Firenze, Italy
Correspondence to Daria Putignano, Helaglobe SRL, Via Leonardo Da Vinci, 16, 50132 Firenze, Italy Tel: +39 0550050130; e-mail: [email protected]
Received 15 July, 2020
Revised 17 September, 2020
Accepted 21 December, 2020
Supplemental digital content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal's Website (www.jcardiovascularmedicine.com).